ArticleAntimicrobial agents and chemotherapy2022
A Novel
Open access · hybridAbstract read
In one paragraph
Article in Antimicrobial agents and chemotherapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 7 citations in OpenAlex.
- Molecular mechanisms involved inFrontiers in microbiology · 2026Review
- An improved multiplex RT-quantitative PCR assay can reveal sex-specific activity of transmission-blocking drugs on ex vivo gametocytes from Plasmodium falciparum asymptomatic infections.The Journal of antimicrobial chemotherapy · 2025Article
- Observational
- Plasmodium SEY1 is a novel druggable target that contributes to imidazolopiperazine mechanism of action.Research square · 2024Article
- Article
- Article
- Imidazolopiperazines as next-generation antimalarial agents: a scoping review of efficacy, mechanisms of action and resistance; prospects for future development.Therapeutic advances in infectious diseaseArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
30 authors at 1 institution in 1 country.
Dinkorma T OuologuemMalaria Research and Training Center, Faculty of Medicine and Dentistry, Faculty of Pharmacy, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.ORCID 0000-0002-3955-9843
Laurent DembeleMalaria Research and Training Center, Faculty of Medicine and Dentistry, Faculty of Pharmacy, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Antoine DaraMalaria Research and Training Center, Faculty of Medicine and Dentistry, Faculty of Pharmacy, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Aminatou K KoneMalaria Research and Training Center, Faculty of Medicine and Dentistry, Faculty of Pharmacy, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Nouhoum DialloMalaria Research and Training Center, Faculty of Medicine and Dentistry, Faculty of Pharmacy, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Cheick P O SangareMalaria Research and Training Center, Faculty of Medicine and Dentistry, Faculty of Pharmacy, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Fatoumata I BalloMalaria Research and Training Center, Faculty of Medicine and Dentistry, Faculty of Pharmacy, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
François DaoMalaria Research and Training Center, Faculty of Medicine and Dentistry, Faculty of Pharmacy, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Siaka GoitaMalaria Research and Training Center, Faculty of Medicine and Dentistry, Faculty of Pharmacy, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Aboubecrin S HaidaraMalaria Research and Training Center, Faculty of Medicine and Dentistry, Faculty of Pharmacy, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Aliou TraoreMalaria Research and Training Center, Faculty of Medicine and Dentistry, Faculty of Pharmacy, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Amadou B NiangalyMalaria Research and Training Center, Faculty of Medicine and Dentistry, Faculty of Pharmacy, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Souleymane DamaMalaria Research and Training Center, Faculty of Medicine and Dentistry, Faculty of Pharmacy, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Sekou SissokoMalaria Research and Training Center, Faculty of Medicine and Dentistry, Faculty of Pharmacy, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Fanta SogoreMalaria Research and Training Center, Faculty of Medicine and Dentistry, Faculty of Pharmacy, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Jacob N DaraMalaria Research and Training Center, Faculty of Medicine and Dentistry, Faculty of Pharmacy, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Yacouba N BarreMalaria Research and Training Center, Faculty of Medicine and Dentistry, Faculty of Pharmacy, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Amadou DaouMalaria Research and Training Center, Faculty of Medicine and Dentistry, Faculty of Pharmacy, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Fatoumata CisseMalaria Research and Training Center, Faculty of Medicine and Dentistry, Faculty of Pharmacy, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Ousmaila DiakiteMalaria Research and Training Center, Faculty of Medicine and Dentistry, Faculty of Pharmacy, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Diagassan DoumbiaMalaria Research and Training Center, Faculty of Medicine and Dentistry, Faculty of Pharmacy, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Sekou KoumareMalaria Research and Training Center, Faculty of Medicine and Dentistry, Faculty of Pharmacy, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Bakary FofanaMalaria Research and Training Center, Faculty of Medicine and Dentistry, Faculty of Pharmacy, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Fatalmoudou TandinaMalaria Research and Training Center, Faculty of Medicine and Dentistry, Faculty of Pharmacy, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Daman SyllaMalaria Research and Training Center, Faculty of Medicine and Dentistry, Faculty of Pharmacy, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Adama SackoMalaria Research and Training Center, Faculty of Medicine and Dentistry, Faculty of Pharmacy, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Mamadou CoulibalyMalaria Research and Training Center, Faculty of Medicine and Dentistry, Faculty of Pharmacy, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Mamadou M TeketeMalaria Research and Training Center, Faculty of Medicine and Dentistry, Faculty of Pharmacy, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Amed OuattaraMalaria Research and Training Center, Faculty of Medicine and Dentistry, Faculty of Pharmacy, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
Abdoulaye A DjimdeMalaria Research and Training Center, Faculty of Medicine and Dentistry, Faculty of Pharmacy, University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
University of Maryland, Baltimore · US
Funding
Designing a diversity-covering multiantigen multi-strain vaccineK01HL140285 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI OUATTARA, AMED · 2019 to 2023
$712kNHLBI NIH HHS K01 HL140285
Abstract
The discovery and development of transmission-blocking therapies challenge malaria elimination and necessitate standard and reproducible bioassays to measure the blocking properties of antimalarial drugs and candidate compounds. Most of the current bioassays evaluating the transmission-blocking activity of compounds rely on laboratory-adapted
Indexed as
AntimalarialsMalaria, FalciparumArtemisininsChloroquineDinitrobenzenesHumansPlasmodium falciparumPrimaquineSulfanilamidesAntimalarialsArtemisininsartenimolChloroquineDinitrobenzenesoryzalinPrimaquineSulfanilamidesculturedirect membrane feeding assaydrug assayex vivofield-isolated gametocytestransmission-blocking activity
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.